Concepedia

Author

Noriaki Maruyama

Nihon University

Also Known As

Noriaki MARUYAMA, Noriaki Maruyama

61

Publications

1.2K

Citations

20

H-Index

43

Concepts

All Affiliations

Nihon UniversityWeatherford CollegeKeiai University
NM

About

Noriaki Maruyama is an author at Nihon University specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

302

2

Health Sciences

1

1

30

3

Natural Sciences

1

1

14

4

Biochemistry

1

1

14

5

Chemistry

1

1

14

Noriaki Maruyama

×

30

Publications

1.1K

Citations

20

H-Index

YearCitations

Antirheumatic Agents:  Novel Methotrexate Derivatives Bearing a Benzoxazine or Benzothiazine Moiety

Hiroharu Matsuoka, N. OHI, Masahiko Mihara,

Journal of Medicinal Chemistry

1997

156

Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy

Masanori Abe, Noriaki Maruyama, Kazuyoshi Okada,

Journal of Atherosclerosis and Thrombosis

2011

104

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis

Hiroki Kobayashi, Masanori Abe, Kazuyoshi Okada,

Nutrients

2015

83

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

Midori Ito, Masanori Abe, Kazuyoshi Okada,

Endocrine Journal

2011

76

Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial

Hiroyuki Takashima, Yoshinori Yoshida, Chinami Nagura,

Diabetes and Vascular Disease Research

2018

54

Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria

Masanori Abe, Kazuyoshi Okada, Noriaki Maruyama,

Hypertension Research

2010

46

Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients

Noriaki Maruyama, Tomoyasu Otsuki, Yoshinori Yoshida,

American Journal of Nephrology

2018

42

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

Yuki Fujii, Masanori Abe, Terumi Higuchi,

Expert Opinion on Pharmacotherapy

2013

41

Prolonged Protective Effect of Short Daily Hemodialysis against Dialysis-Induced Hypotension

Kazuyoshi Okada, Masanori Abe, Chihiro Hagi,

Kidney & Blood Pressure Research

2005

36

Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney disease

Masanori Abe, Kazuyoshi Okada, Takashi Maruyama,

Hypertension Research

2009

35

Page 1